Table 1.
Patient characteristics | |
Gender (female/male) | 9 (9/0) |
Age, mean (range), years | 70.6 (55–83) |
Disease duration, mean (range), years | 11.2 (7–20) |
CRP, mean (range), mg/dl | 0.60 (0.07–2.3) |
ESR, mean (range), mm/h | 36.8 (6–88) |
MMP-3, mean (range), ng/ml | 260.9 (40.5–660.4) |
Seropositive/seronegative/unknown, N | 5/3/1 |
ACPA positive/negative, N | 4/2 |
Steinbrocker stage, II/III/IV, N | 1/5/3 |
Patients using DMARDs | |
Methotrexate, N | 8 |
Bucillamine, N | 2 |
TNF inhibitors, N | 5 |
Patients using oral steroids, N | 6 |
RA, rheumatoid arthritis; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MMP, matrix metalloproteinase; ACPA, anti-cyclic citrullinated peptide antibody; DMARDs, disease-modifying antirheumatic drugs; TNF, tumor necrosis factor; N, number